PAPERS & POSTERS

BNC210

Subjective Units of Distress Scale (SUDS) is a psychometrically valid and reliable outcome measure for the assessment of anxiety in social anxiety disorder (SAD) clinical trials

8 Dec 2023 Download (252Kb) (252Kb)

Development of an Improved Oral Tablet Formulation of BNC210, a Negative Allosteric Modulator of the α7 nAChR, Suitable for Evaluation as an Acute Treatment for Social Anxiety Disorder

5 Dec 2022 Download (1.7Mb) (1.7Mb)

Pharmacometrics Analysis and Drug Reformulation of BNC210 to Optimize its Evaluation in a Phase 2 Trial in PTSD Patients

6 Dec 2022 Download (2.6Mb) (2.6Mb)

Cholinergic modulation of disorder-relevant human defensive behaviour in generalised anxiety disorder

1 Jan 2021 Download (957Kb) (957Kb)

Cholinergic Modulation of Disorder-Relevant Neural Circuits in Generalized Anxiety Disorder

1 May 2020 Download (595Kb) (595Kb)

α7 Receptor PAM

Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs

31 Dec 2018 Download (943Kb) (943Kb)